"We've added red sensitivity to cone cells in animals that are born with a condition that is exactly like human colour-blindness," William W. Hauswirth, a professor of ophthalmic molecular genetics at the UF College of Medicine, said in a statement.
But even if you can cure monkeys of colour-blindness, how would you know?
The answer begins 10 years ago when Jay and Maureen Neitz — both ophthalmology professors at the University of Washington, and authors on the study — began training two squirrel monkeys named Dalton and Sam.
The couple also worked with the makers of the Cambridge Colour Test, a standard colour-blindness test using patterns of coloured dots, to adapt the test to non-human subjects. The researchers devised a computer touch screen that the monkeys could use to trace the patterns on the screen. When they correctly identified the pattern, the monkeys were rewarded with
'It was if they woke up and saw these new colours … colours that had been invisible to them.'—Jay Neitz, study co-author
Hauswirth and colleagues at the University of Florida developed the gene therapy technique used in the experiment. The scientists wanted to produce a protein involved in red-green light sensitivity, called long-wavelength opsin, in the monkeys.
The genes that code for opsin were introduced into the monkeys using a harmless virus that incorporates its DNA into the host cell.
Used human DNA in experiment
"We used human DNA, so we won't have to switch to human genes as we move toward clinical treatments," said Hauswirth.
In the study, published this week in the journal Nature, the squirrel monkeys began to show signs of colour vision about five weeks after the gene treatment.
CBC Radio's Quirks and Quarks will have an interview with Jay Neitz, Sat., Sept. 19.
"It was if they woke up and saw these new colours. The treated animals unquestionably responded to colours that had been invisible to them," said Jay Neitz.
It took more than a year and a half for the researchers to test the monkeys' ability to see 16 different hues.
"If we could find a way to do this with complete safety in human eyes, as we did with monkeys, I think there would be a lot of people who would want it. Beyond that, we hope this technology will
Genetic disorders of the cone cells in the eyes include achromatopsia, which causes poor central vision, as well as complete colour-blindness. The researchers said the same treatment could potentially cure this disease, as well as vision problems associated with aging and diabetes.
Dalton the squirrel monkey enjoys a green bean after treatment for colour-blindness. Before treatment, the bean would have appeared grey to the monkey. (Neitz Laboratory)